[96a5a0]: / output / chiaCancer / identified / NCT02816164_identified.json

Download this file

135 lines (135 with data), 4.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
{
"info": {
"nct_id": "NCT02816164",
"official_title": "A Multi Centre Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (REaCT-G2)",
"inclusion_criteria": "* Histologically confirmed primary breast cancer\n* Planned to start docetaxel component of FEC-D or AC-D, or first cycle of; dose-dense AC-T, TC, FEC-D or TAC chemotherapy\n* ≥19 years of age\n* Able to provide verbal consent\nHealthy volunteers allowed\nMust have minimum age of 19 Years",
"exclusion_criteria": "* Contraindication to Filgrastim",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically confirmed primary breast cancer",
"criterions": [
{
"exact_snippets": [
"Histologically confirmed"
],
"criterion": "breast cancer",
"requirement_type": "confirmation method",
"expected_value": "histological"
},
{
"exact_snippets": [
"primary breast cancer"
],
"criterion": "breast cancer",
"requirement_type": "type",
"expected_value": "primary"
}
]
},
{
"line": "* Planned to start docetaxel component of FEC-D or AC-D, or first cycle of; dose-dense AC-T, TC, FEC-D or TAC chemotherapy",
"criterions": [
{
"exact_snippets": [
"Planned to start docetaxel component of FEC-D or AC-D"
],
"criterion": "docetaxel component of FEC-D or AC-D",
"requirement_type": "planned start",
"expected_value": true
},
{
"exact_snippets": [
"first cycle of; dose-dense AC-T, TC, FEC-D or TAC chemotherapy"
],
"criterion": "dose-dense AC-T, TC, FEC-D or TAC chemotherapy",
"requirement_type": "first cycle",
"expected_value": true
}
]
},
{
"line": "* Able to provide verbal consent",
"criterions": [
{
"exact_snippets": [
"Able to provide verbal consent"
],
"criterion": "verbal consent",
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "volunteer health status",
"requirement_type": "allowance",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 19 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 19 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 19
}
}
]
}
],
"exclusion_lines": [
{
"line": "* Contraindication to Filgrastim",
"criterions": [
{
"exact_snippets": [
"Contraindication to Filgrastim"
],
"criterion": "Filgrastim",
"requirement_type": "contraindication",
"expected_value": true
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* ≥19 years of age",
"criterions": [
{
"exact_snippets": [
">=19 years of age"
],
"criterion": "age",
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 19
}
]
}
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}